Schulhoff & CO Inc Eli Lilly & CO Transaction History

Schulhoff & CO Inc

$206 Million
Q2 2024

A detailed history of Schulhoff & CO Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Schulhoff & CO Inc holds 4,880 shares of LLY stock, worth $4.33 Million. This represents 2.14% of its overall portfolio holdings.

Number of Shares

4,880

Previous 4,880 -0.0%

Holding current value

$4.33 Million

Previous $3.8 Million 16.39%

% of portfolio

2.14%

Previous 1.78%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $118,440 - $158,456	-200 Reduced 3.94%	4,880 $3.8 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $15,755 - $18,573	-30 Reduced 0.59%	5,080 $2.96 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $28,255 - $38,954	-65 Reduced 1.26%	5,110 $2.74 Million
Q3 2021 Nov 08, 2021	BUY	$221.6 - $272.71 $11,080 - $13,635	50 Added 0.98%	5,175 $1.2 Million
Q2 2021 Aug 03, 2021	SELL	$180.55 - $233.54 $23,471 - $30,360	-130 Reduced 2.47%	5,125 $1.18 Million
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $101,878 - $131,886	-620 Reduced 10.55%	5,255 $981,000
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $65,230 - $86,315	-500 Reduced 7.84%	5,875 $991,000
Q2 2020 Jul 29, 2020	SELL	$136.42 - $164.18 $30,694 - $36,940	-225 Reduced 3.41%	6,375 $1.05 Million
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $53,395 - $58,080	-500 Reduced 7.04%	6,600 $738,000
Q1 2019 Apr 24, 2019	BUY	$111.31 - $131.02 $19,479 - $22,928	175 Added 2.53%	7,100 $921,000
Q4 2018 Feb 07, 2019	SELL	$105.9 - $118.64 $23,827 - $26,694	-225 Reduced 3.15%	6,925 $801,000
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $158,970 - $182,448	-2,100 Reduced 22.7%	7,150 $610,000
Q3 2017 Oct 25, 2017	BUY	$77.07 - $85.54 $3,853 - $4,277	50 Added 0.54%	9,250 $791,000
Q2 2017 Aug 08, 2017	BUY	N/A	9,200	9,200 $757,000

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schulhoff & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schulhoff & CO Inc with notifications on news.

Account